IWC
XLRN

Integrated Wealth Concepts’s Acceleron Pharma XLRN Stock Holding History

Integrated Wealth Concepts’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,000
Closed -$265K – 491
2019
Q4 		$265K Buy
+5,000
New +$228K 0.02% 390
2019
Q3 		– Sell
-5,000
Closed -$205K – 443
2019
Q2 		$205K Hold
5,000
– – 0.03% 360
2019
Q1 		$233K Hold
5,000
– – 0.04% 288
2018
Q4 		$218K Hold
5,000
– – 0.06% 238
2018
Q3 		$279K Hold
5,000
– – 0.08% 189
2018
Q2 		$237K Buy
+5,000
New +$182K 0.08% 188

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Integrated Wealth Concepts's XLRN Position: Q1 2020 in Review

Integrated Wealth Concepts sold out of Acceleron Pharma (XLRN) in Q1 2020, closing a stake of 5,000 shares — an estimated $265K sold.

Integrated Wealth Concepts first reported a position in XLRN in Q2 2018 and held it in 6 quarters. The position peaked at $279K in Q3 2018. 217 funds tracked by Wall St. Rank hold XLRN as of Q1 2020.

  • Integrated Wealth Concepts reported no remaining Acceleron Pharma position as of Q1 2020 after selling out during the quarter.
  • Integrated Wealth Concepts sold 5,000 Acceleron Pharma shares in Q1 2020, an estimated $265K.
  • Integrated Wealth Concepts first reported a position in Acceleron Pharma in Q2 2018 and held it in 6 quarters.
  • Integrated Wealth Concepts's Acceleron Pharma position peaked at $279K in Q3 2018.
  • 217 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2020.

Based on Integrated Wealth Concepts's 13F filing for Q1 2020, filed 18 May 2020.